Skip to content
10-Q

Quarterly Report

NEUROPACE, INC. NPCE

0001528287-26-000022

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 34.09M sh
Shares Diluted Q1 2026 · Mar 31, 2026 33.72M sh
Shares Diluted Q1 2026 · Mar 31, 2025 31.48M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $49.55M
Capex Q1 2026 · Mar 31, 2026 $117K
Capex Q1 2026 · Mar 31, 2025 $37K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$5.9M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$7.48M
Long Term Debt Q1 2026 · Mar 31, 2026 $59.02M
Long Term Debt Q1 2026 · Dec 31, 2025 $58.88M
Short Term Investments Q1 2026 · Mar 31, 2026 $39.2M
Short Term Investments Q1 2026 · Dec 31, 2025 $39.37M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $14.78M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $21.69M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $27.02M
Stockholders Equity Q1 2026 · Mar 31, 2026 $14.45M
Stockholders Equity Q1 2026 · Dec 31, 2025 $19.03M
Stockholders Equity Q1 2026 · Mar 31, 2025 $24.27M
Stockholders Equity Q1 2026 · Dec 31, 2024 $8.01M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.17M
Current Liabilities Q1 2026 · Dec 31, 2025 $17.81M
Total Liabilities Q1 2026 · Mar 31, 2026 $84.44M
Total Liabilities Q1 2026 · Dec 31, 2025 $86.53M
Current Assets Q1 2026 · Mar 31, 2026 $86.98M
Current Assets Q1 2026 · Dec 31, 2025 $94.07M
Total Assets Q1 2026 · Mar 31, 2026 $98.9M
Total Assets Q1 2026 · Dec 31, 2025 $105.57M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.20
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.21
Eps Basic Q1 2026 · Mar 31, 2026 −$0.20
Eps Basic Q1 2026 · Mar 31, 2025 −$0.21
Rd Expense Q1 2026 · Mar 31, 2026 $7.19M
Rd Expense Q1 2026 · Mar 31, 2025 $7.44M
Net Income Q1 2026 · Mar 31, 2026 −$6.69M
Net Income Q1 2026 · Mar 31, 2025 −$6.59M
Operating Income Q1 2026 · Mar 31, 2026 −$5.57M
Operating Income Q1 2026 · Mar 31, 2025 −$5.15M
Gross Profit Q1 2026 · Mar 31, 2026 $18.05M
Gross Profit Q1 2026 · Mar 31, 2025 $17.34M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $4.02M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $5.18M
Revenue Q1 2026 · Mar 31, 2026 $22.07M
Revenue Q1 2026 · Mar 31, 2025 $22.52M